Navigation Links
TGen's Dr. Von Hoff wins award for cancer research

PHOENIX, Ariz. March 18, 2009 Dr. Daniel Von Hoff, Physician-In-Chief of the Translational Genomics Research Institute (TGen), has won an award recognizing his achievements in cancer research.

Dr. Von Hoff, who also is Chief Scientific Officer of TGen Clinical Research Services at Scottsdale Healthcare, will be recognized in the category of Health Care Research in a special report this month in Arizona Business Magazine. Dr. Von Hoff was honored March 4 at the magazine's 2009 Health Care Leadership Awards at the Ritz Carlton Phoenix.

This is the second major award in recent months for Dr. Von Hoff, a world-renowned cancer scientist and one of the leading experts in pancreatic cancer. In November, Dr. Von Hoff was named Arizona's Community Service Leader of the Year at the 2008 Governor's Celebration of Innovation, presented annually for contributions to Arizona's technology industry through relentless community involvement, leadership, visibility and excellence in economic development activity.

For more than 30 years, Dr. Von Hoff has dedicated his time and experience to the study of cancer and treatment methods. Arizona Business Magazine cited his:

  • International leadership in bringing to patients new anti-cancer agents many of which have been shown to increase patient survival.

  • Study of pancreatic and other forms of cancer.

  • Dedication to teaching.

  • Entrepreneurial research efforts, which have led to 12 patents.

Through the three-year-old partnership between TGen and Scottsdale Healthcare, Dr. Von Hoff leads a nearly 40-member staff in the research and treatment of cancer. TCRS at Scottsdale Healthcare is conducting 35 ongoing studies, involving the treatment of many patients with advanced cancer. The alliance works to identify new anti-cancer agents, and strives to bring diagnostic and treatment options to patients as fast as possible.

Dr. Von Hoff earned his medical degree from Columbia College of Physicians and Surgeons. He held an internship and residency at the University of California, San Francisco; conducted four years of cancer research at the National Cancer Institute; and worked as a faculty member at the University of Texas.

In Arizona, he has worked as Director of the Arizona Cancer Center in Tucson and as a Clinical Professor at the University of Arizona College of Medicine.

Dr. Von Hoff holds a presidential appointment to the National Cancer Advisory Board, is widely published and has been a keynote speaker at numerous national and international medical and scientific conferences.


Contact: Steve Yozwiak
The Translational Genomics Research Institute

Related biology news :

1. DOE awards UGA $3.1 million to support complex carbohydrate study nationwide
2. Lehigh researcher awarded $1.8 million NIH grant
3. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
4. Dr. King receives IADR Craniofacial Biology Research Award
5. Christopher McCulloch receives the IADR Research in Oral Biology Award
6. IADR Wilmer Souder Award presented to University of Colorado professor
7. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
8. Oxfords Dr. Rosalind Rickaby receives 2009 Rosenstiel Award
9. Sea Grant awards $820,000 for research under EPAs Long Island Sound study
10. NYU College of Dentistry awarded $1.9 million NIH grant for HIV research
11. Lincoln Park Zoo scientists awarded National Institutes of Health grant
Post Your Comments:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... 17, 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... and sale of broadly enabling, pressure cycling technology ("PCT")-based ... today announced it has received gross proceeds of $745,000 ... Placement (the "Offering"), increasing the total amount raised to ... additional closings are expected in the near future. ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , Chief ... Annual Healthcare Conference in New York City , ... p.m. GMT). --> SHPG ) announced today that ... Jaffray 27 th Annual Healthcare Conference in New ... 8:30 a.m. EST (1:30 p.m. GMT). --> Shire plc ...
(Date:11/24/2015)... 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its ... at 11:00 a.m. Israel time, at the law ... Allon Street, 36 th Floor, Tel Aviv, Israel ... and Izhak Tamir to the Board of Directors; ... directors; , approval of an amendment to certain terms of options ...
(Date:11/24/2015)... SAN FRANCISCO , Nov. 24, 2015 /PRNewswire/ ... today announced that Emily Leproust, Ph.D., Twist Bioscience ... Piper Jaffray Healthcare Conference on December 1, 2015 ... Palace Hotel in New York City. ... . Twist Bioscience is on ...
(Date:11/24/2015)... ... ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and ... as Chief Operating Officer. , Having joined InSphero in November 2013 as ... promoted to Head of InSphero Diagnostics in 2014. There she has built up ...
Breaking Biology Technology: